cilostazol
Generic: cilostazol
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
cilostazol
Generic Name
cilostazol
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
cilostazol 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-822
Product ID
71610-822_15ead24d-7d6b-b7ad-e063-6294a90ab1bb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077030
Listing Expiration
2026-12-31
Marketing Start
2011-10-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610822
Hyphenated Format
71610-822
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cilostazol (source: ndc)
Generic Name
cilostazol (source: ndc)
Application Number
ANDA077030 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 1200 TABLET in 1 BOTTLE (71610-822-26)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "15ead24d-7d6b-b7ad-e063-6294a90ab1bb", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242461"], "spl_set_id": ["15ead884-bd4f-7f4b-e063-6394a90a8f81"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1200 TABLET in 1 BOTTLE (71610-822-26)", "package_ndc": "71610-822-26", "marketing_start_date": "20240412"}], "brand_name": "cilostazol", "product_id": "71610-822_15ead24d-7d6b-b7ad-e063-6294a90ab1bb", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "71610-822", "generic_name": "cilostazol", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "100 mg/1"}], "application_number": "ANDA077030", "marketing_category": "ANDA", "marketing_start_date": "20111018", "listing_expiration_date": "20261231"}